UNSPSC 51112605: Galamustine

This classification denotes a nitrogen mustard compound with the molecular formula C10H19Cl2NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P771FDQ1WJ, chemically known as d-galactopyranose, 6-(bis(2-chloroethyl)amino)-6-deoxy- but more generally known as galamustine, which bears US NIH Compound Identifier 65891. European Medicines Agency schedules Galamustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07869MIG.

UNSPSC 51112605 Galamustine is a Commodity code covering the procurement of this nitrogen mustard chemotherapy agent by state and local health systems, cancer treatment centers, and hospital pharmacy departments. State and local governments buy galamustine primarily as a pharmaceutical input for oncology services delivered through public health departments, state university medical centers, county hospitals, and municipal health authorities. The drug is sourced through state pharmaceutical cooperative purchasing vehicles, group purchasing organizations (GPOs), and direct procurement from licensed pharmaceutical wholesalers and manufacturers.

The source provided contains no recent state and local contract opportunities tagged to this code. Without posted solicitations or awarded contracts in the available record, the geographic scope and issuing-body concentration cannot be characterized from current activity.